Similar articles

• Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis.

  Anderson IM, Tomenson BM. Anderson IM, et al. BMJ. 1995 Jun 3;310(6992):1433-8. doi: 10.1136/bmj.310.6992.1433. BMJ. 1995. PMID: 7613276 Free PMC article.
• One foot on the bandwagon?

  Pies R. Pies R. J Clin Psychopharmacol. 1995 Oct;15(5):303-5. doi: 10.1097/00004714-199510000-00001. J Clin Psychopharmacol. 1995. PMID: 8830060 Review. No abstract available.
• An analysis of the diffusion of new antidepressants: variety, quality, and marketing efforts.

  Berndt ER, Bhattacharjya A, Mishol DN, Arcelus A, Lasky T. Berndt ER, et al. J Ment Health Policy Econ. 2002 Mar;5(1):3-19. J Ment Health Policy Econ. 2002. PMID: 12529566
• The importance of accidents in evaluating the cost of SSRIs: a review.

  Hale AS. Hale AS. Int Clin Psychopharmacol. 1994 Sep;9(3):195-201. doi: 10.1097/00004850-199409000-00008. Int Clin Psychopharmacol. 1994. PMID: 7814829 Review.
• Are SSRIs a cost-effective alternative to tricyclics?

  Hotopf M, Lewis G, Normand C. Hotopf M, et al. Br J Psychiatry. 1996 Apr;168(4):404-9. doi: 10.1192/bjp.168.4.404. Br J Psychiatry. 1996. PMID: 8730935